Innoviva (INVA) Tax Provisions (2014 - 2026)
Innoviva (INVA) posted Tax Provisions of $48.0 million for Q1 2026, up 93.42% on a QoQ basis from $24.8 million in Q3 2025, and up 499.6% year-over-year from $8.0 million in Q1 2025.
Innoviva (INVA) Tax Provisions (2014 - 2026) Analysis & Trends
Innoviva's Tax Provisions history runs 11 years deep, the most recent figure standing at $48.0 million for Q1 2026.
- Quarterly Tax Provisions rose 499.6% year-over-year to $48.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89.7 million (up 315.06% YoY) and the FY2024 annual result came in at $26.6 million, up 1757.15% from the prior year.
- Tax Provisions was $48.0 million for Q1 2026 at Innoviva, up from $24.8 million in the prior quarter.
- Across five years, Tax Provisions topped out at $63.1 million in Q3 2022 and bottomed at -$4.6 million in Q2 2024.
- A 5-year average of $15.2 million and a median of $8.6 million in 2024 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions surged 600.0% — and 2024, when it tumbled 202.09%.
- Innoviva's Tax Provisions stood at $63.1 million in 2022, then plunged by 76.68% to $14.7 million in 2023, then sank by 34.72% to $9.6 million in 2024, then jumped by 158.33% to $24.8 million in 2025, then jumped by 93.42% to $48.0 million in 2026.
- Business Quant data shows INVA's Tax Provisions at $48.0 million in Q1 2026, $24.8 million in Q3 2025, and $8.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Innoviva | 1.59 Bn | 983.20 Mn | 75.83 Mn | 47.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.97 Mn |
| Sep 30, 2025 | 24.80 Mn |
| Jun 30, 2025 | 8.91 Mn |
| Mar 31, 2025 | 8.00 Mn |
| Sep 30, 2024 | 9.60 Mn |
| Jun 30, 2024 | -4.59 Mn |
| Mar 31, 2024 | 8.60 Mn |
| Sep 30, 2023 | 14.71 Mn |
| Jun 30, 2023 | 4.50 Mn |
| Mar 31, 2023 | 6.30 Mn |
| Sep 30, 2022 | 63.06 Mn |
| Jun 30, 2022 | -900,000.00 |
| Mar 31, 2022 | 6.86 Mn |
| Sep 30, 2021 | 65.60 Mn |
| Jun 30, 2021 | 25.33 Mn |
| Mar 31, 2021 | 19.70 Mn |
| Dec 31, 2020 | -44.69 Mn |
| Sep 30, 2020 | 8.90 Mn |
| Jun 30, 2020 | 19.89 Mn |
| Mar 31, 2020 | 15.93 Mn |